A phase 2 trial shows combining intravesical recombinant BCG with chemoimmunotherapy in MIBC yields a higher than expected pathologic complete response rate. Intravesical recombinant bacillus Calmette ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果